Promoter DNA methylation determined by Methylation specific PCR (MSP) assay revealed that D2R promoter DNA methylation was increased in the pituitary of AF rats compared to AD and PF controls at 60D and 90D after estrogen treatment (Fig 4B and 4C). Here, DRD2 is linked to Alzheimer disease.